← All tickers

Is CCCC Worth Buying in 2026?

C4 Therapeutics, Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-05-03

Here’s whether C4 Therapeutics, Inc. (CCCC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+8.03% over 10 days); RSI 56 — healthy momentum range; strong 1-year return of +79.1%; 3-month momentum positive (+55.3%). Currently 23.6% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

CCCC is in a confirmed uptrend, trading above both its 50-day ($2.79) and 200-day ($2.45) moving averages. An RSI of 56.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +79.1% compares to +27.9% for SPY (beat the market by 51.3%). The current 23.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $17,914 today
vs. S&P 500 (SPY) — same period beat market by 51.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($2.45)
✓Above 50-day MA ($2.79)
✓RSI(14) neutral zone (30–70) — currently 56.3
✓Positive return (+79.1%)
!Within 10% of period high (−23.6%)
Period Range $2.92
$1.21 $3.82
RSI (14) 56.3
0 · OversoldOverbought · 100

Key Metrics

Price$2.92
Period Return+79.1%
Period High$3.82
Period Low$1.21
Drawdown−23.6%
MA-50$2.79
MA-200$2.45
RSI (14)56.3
Avg Volume (30d)2.8M
vs. SPYbeat by 50.1%
Return Rank#273 of 1236

Trade CCCC

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers